Vaccine History

The history of vaccination spans more than two thousand years, from early efforts to protect people against smallpox to modern vaccine platforms developed in the 21st century. Over time, vaccination has also been shaped by military medicine, colonial public health, industrial manufacturing, legal mandates, civil liberties movements, and global eradication campaigns. This introduction offers a chronological overview of major developments, drawing on regulatory records, historical research, and institutional archives. Every factual claim below is attributed to a named source; readers seeking the full chronological record can explore our General Vaccine History Timeline (396 entries) and Vaccine Safety Historical Timeline (61 entries).

Ancient Origins: Variolation in Asia, Africa, and the Middle East

The earliest documented efforts to induce immunity targeted smallpox, a disease that the CDC estimates killed approximately 30% of those infected (History of Smallpox, CDC, 2024). The first known technique, variolation, involved exposing a healthy person to material from a smallpox sore in hopes of causing a milder infection that would provide later protection. According to the College of Physicians of Philadelphia's History of Vaccines project, the practice originated in Asia, likely in China or India, and may have arisen independently in both regions (The History of Variolation, History of Vaccines, 2021).

In China, one documented method involved drying smallpox scabs and blowing the resulting powder into the nostrils of the person being treated, a method sometimes described as nasal insufflation. The first clear written reference to this practice appears in the work of the Chinese physician Wan Quan, published in 1549 (Variolation, Wikipedia, citing Needham). British sinologist Joseph Needham dated the method's broader adoption to the Longqing reign period, between 1567 and 1572 (Needham, as cited in Variolation, Wikipedia). In India, Brahmin practitioners known as tikadars carried out door-to-door inoculation using material from smallpox pustules introduced through skin scratches, a practice described in 18th-century European accounts (Association for Asian Studies, Rinaldi, 2023).

Variolation reached Europe through two channels in the early 18th century. In 1714, the physician Emanuel Timoni described the Ottoman practice in a letter published in the Royal Society's Philosophical Transactions (Riedel, Proc. Baylor Univ. Med. Cent., 2005). More famously, Lady Mary Wortley Montagu, wife of the British ambassador to the Ottoman Empire, observed variolation in Istanbul and in 1721 arranged for the inoculation of her daughter in the presence of royal court physicians, an event that helped popularize the procedure in England (Riedel, 2005). Across the Atlantic, the Puritan minister Cotton Mather learned of a similar practice from Onesimus, an enslaved man from Libya, and worked with physician Zabdiel Boylston to inoculate residents during Boston's 1721 smallpox epidemic. Of those inoculated, approximately 2% died, compared to approximately 14% of those who contracted smallpox naturally (The History of Variolation, History of Vaccines, 2021).

Edward Jenner and the Birth of Vaccination (1796–1801)

Variolation carried inherent risks: recipients could develop full smallpox and transmit it to others, and the procedure could also spread bloodborne diseases such as syphilis (Riedel, 2005). A safer alternative emerged in the English countryside. On May 14, 1796, physician Edward Jenner inoculated eight-year-old James Phipps with material taken from a cowpox sore on the hand of a milkmaid, Sarah Nelmes. In July 1796, Jenner challenged Phipps with smallpox material; no disease developed (Riedel, Proc. Baylor Univ. Med. Cent., 2005; History of Smallpox, CDC, 2024).

Jenner published his findings privately in 1798 in a work titled An Inquiry into the Causes and Effects of the Variolae Vaccinae, after the Royal Society declined his initial paper (Riedel, 2005). The word 'vaccine' derives from the Latin vacca (cow), reflecting the cowpox origin of Jenner's method (A Brief History of Vaccination, WHO). By 1803, Jenner's findings had been translated into French and Spanish, and the King of Spain launched a vaccination campaign reaching the Americas and the Far East (Edward Jenner, FRS FRCPE, History of Vaccines). Mandatory smallpox vaccination laws followed in Britain and parts of the United States during the 1840s and 1850s (History of Smallpox Vaccination, WHO).

Jenner was not the first person to observe that cowpox might protect against smallpox. As early as 1774, the Dorset farmer Benjamin Jesty inoculated his family with cowpox during a local epidemic, and physician John Fewster had discussed the possibility of cowpox inoculation at medical meetings as early as 1765 (Smallpox vaccine, Wikipedia, citing Jenner scholarship). Jenner's contribution was to document the method systematically and help spread it more widely.

The 19th Century: Germ Theory, Pasteur, and the Rise of Bacteriology

For most of the 19th century, smallpox remained the only disease targeted by vaccination. The primary distribution method was arm-to-arm transfer of vaccine material between individuals, a practice that could inadvertently transmit other diseases. After the 1840s, calves began to be used to propagate vaccine material, reducing this risk and allowing larger-scale production (History of Smallpox Vaccination, WHO).

In the second half of the century, scientific understanding of infectious disease changed dramatically. Louis Pasteur's research during the 1860s and 1870s helped establish the germ theory of disease, replacing the prevailing miasma theory that attributed illness to 'bad air' (Louis Pasteur, Science History Institute). In 1879, Pasteur discovered that cultures of the bacterium causing chicken cholera lost their virulence over time but could still induce protective immunity when inoculated into birds — showing the principle of attenuation, in which a weakened pathogen can still produce immunity (Louis Pasteur: Vaccine Development, Britannica). He applied this principle to develop a vaccine against anthrax in livestock in 1881 (Louis Pasteur, Science History Institute).

On July 6, 1885, Pasteur and his colleague Dr. Jacques-Joseph Grancher administered an attenuated rabies vaccine to nine-year-old Joseph Meister, who had been bitten fourteen times by a rabid dog. Meister recovered fully, and the treatment's success led to the founding of the Institut Pasteur in Paris in 1888 (The History of the First Rabies Vaccination in 1885, Institut Pasteur, 2023; Louis Pasteur, Britannica). The rabies vaccine was the first vaccine developed through deliberate laboratory attenuation of a pathogen, establishing the scientific methodology that would underpin vaccine development for the next century.

The Early 20th Century: Regulation, World Wars, and Expanding Immunization

By the early 1900s, a growing portfolio of vaccines and antitoxins became available, including products for diphtheria, tetanus, typhoid, plague, cholera, and tuberculosis (BCG). As more biological products entered use, and some created safety risks, governments began putting the first regulatory systems in place. In the United States, a contaminated diphtheria antitoxin linked to the deaths of children in St. Louis in 1901 led to the passage of the Biologics Control Act of 1902, which established federal oversight of vaccine production (Vaccine Safety Historical Timeline, entry for 1902).

The First and Second World Wars accelerated both the development and the mass deployment of vaccines. Military populations were often among the first to receive new vaccines, and the wars also drove research into biological agents and countermeasures. The ethical failures of human experimentation during the Second World War — documented at the Nuremberg trials — led to the creation of the Nuremberg Code in 1947, establishing the principle of voluntary informed consent as a foundation of ethical research (General Vaccine History Timeline, entry for 1947).

By the late 1940s, the first combined vaccine — DTP (diphtheria, tetanus, whole-cell pertussis) — was commercialized, and the freeze-drying technique was applied to vaccine production, improving storage and transport. This period also saw the establishment of the World Health Organization (WHO) in 1948, which would become the central coordinating body for global immunization efforts.

The Mid-20th Century: Polio, Cell Culture, and the Modern Vaccine Era

The 1950s and 1960s represented a period of rapid vaccine development, driven in large part by advances in cell culture techniques that reduced the need for live animals in vaccine production. Jonas Salk's inactivated polio vaccine was licensed in 1955, followed by Albert Sabin's live oral polio vaccine in the early 1960s. Vaccines against measles (1963), mumps (1967), and rubella (1969) were also licensed during this period (General Vaccine History Timeline).

This era also brought the discovery of unintended viral contamination in vaccine production. Simian virus 40 (SV40), a monkey virus associated with cancer in some research contexts, was identified as a contaminant in some batches of polio vaccine produced from rhesus monkey kidney cells — a finding that contributed to subsequent improvements in manufacturing quality controls (Vaccine Safety Historical Timeline).

The regulatory landscape continued to evolve. Following the thalidomide tragedy in the early 1960s, the U.S. Congress passed the 1962 Kefauver-Harris Amendment, requiring pharmaceutical manufacturers to demonstrate both safety and efficacy before a product could be licensed (General Vaccine History Timeline, entry for 1962).

The Late 20th Century: Recombinant Technology, Liability Reform, and Schedule Expansion

Beginning in the 1970s, recombinant DNA technology opened new ways to design vaccines. The first vaccine produced using genetic engineering — a recombinant hepatitis B vaccine — was licensed in the 1980s, replacing an earlier plasma-derived product. This shift toward genetically engineered vaccines continued through the 1990s, with the development of improved products against meningitis, rotavirus, pertussis, and pneumococcal disease (Vaccine Catalog).

In the United States, the National Childhood Vaccine Injury Act (NCVIA) of 1986 created a no-fault compensation system — the Vaccine Injury Compensation Program (VICP) — and provided liability protections for vaccine manufacturers. The legislation was enacted in response to a wave of lawsuits that had threatened the domestic vaccine supply (VICP page and Legal History page). The childhood vaccination schedule expanded considerably during this period, with new combination vaccines and additional doses added to the recommended schedule.

Smallpox Eradication: The First and Only Human Disease Eliminated

The most widely recognized milestone in the history of vaccination is the eradication of smallpox. The WHO launched its Intensified Smallpox Eradication Programme in 1967, coordinating mass vaccination campaigns and surveillance-containment strategies across endemic countries. The last naturally occurring case of variola major was identified in Bangladesh in 1975, and the last case of variola minor was recorded in Somalia on October 26, 1977 (Commemorating Smallpox Eradication, WHO, 2020). On December 9, 1979, the Global Commission for the Certification of Smallpox Eradication certified that smallpox had been eliminated worldwide. The 33rd World Health Assembly formally accepted this certification on May 8, 1980, declaring that 'the world and all its peoples have won freedom from smallpox' (WHO, 1980). Smallpox remains the only human disease to have been eradicated.

The 21st Century: Genomics, mRNA Platforms, and Ongoing Expansion

The early 21st century has been shaped by advances in genomics, synthetic biology, and platform-based vaccine design. The human papillomavirus (HPV) vaccine was licensed in 2006, the first vaccine developed with the explicit aim of preventing a specific cancer. Conjugate vaccines expanded protection against meningococcal and pneumococcal disease across broader ranges of bacterial strains (serotypes) (Vaccine Catalog, Meningococcal and Pneumococcal pages).

The COVID-19 pandemic, beginning in 2020, accelerated the deployment of mRNA vaccine technology at a scale not previously attempted. Both the Pfizer-BioNTech and Moderna COVID-19 vaccines received Emergency Use Authorization from the FDA in December 2020, representing the first mRNA vaccines authorized for use in humans (General Vaccine History Timeline, entries for 2020). The pandemic also prompted the first broad application of the Emergency Use Authorization pathway for vaccines and renewed public debate over vaccine mandates, exemptions, and informed consent.

As of 2026, the U.S. recommended immunization schedule includes vaccines against more than 20 diseases for children and adolescents, with additional vaccines recommended for adults, healthcare workers, travelers, and special populations. The global vaccine portfolio continues to expand, with conjugate, recombinant, viral vector, and nucleic acid platforms under active development for both infectious and chronic diseases (Vaccine Catalog and Approval Process pages).

How to Use This Section

This page is the entry point to VaccinationFacts.com's historical research. The General Vaccine History Timeline provides a searchable, filterable chronological record of 396 entries spanning 430 BC to the present day, organized across seven era-based subpages. The Vaccine Safety Historical Timeline documents 61 safety events and regulatory responses from 1798 to 2024. Both timelines have been reviewed through our Council of Three editorial process for factual accuracy, scientific rigor, and neutral tone.

Sources

CDC. 'History of Smallpox.' Centers for Disease Control and Prevention, updated November 2024. · History of Vaccines. 'The History of Variolation.' College of Physicians of Philadelphia, 2021. · History of Vaccines. 'Edward Jenner, FRS FRCPE.' College of Physicians of Philadelphia. · Institut Pasteur. 'The History of the First Rabies Vaccination in 1885.' November 2023. · Riedel, Stefan. 'Edward Jenner and the History of Smallpox and Vaccination.' Proc. Baylor Univ. Med. Cent., 18(1): 21-25, 2005. · Rinaldi, Andrea. 'Variolation to Vaccine.' Association for Asian Studies, 2023. · Science History Institute. 'Louis Pasteur.' Scientific biography. · Britannica. 'Louis Pasteur: Vaccine Development.' Updated February 2026. · WHO. 'A Brief History of Vaccination.' · WHO. 'History of Smallpox Vaccination.' · WHO. 'Commemorating Smallpox Eradication.' May 8, 2020. · WHO. 'The Global Eradication of Smallpox: Final Report of the Global Commission.' Geneva, December 1979 (published 1980). · VaccinationFacts.com General Vaccine History Timeline (396 entries). · VaccinationFacts.com Vaccine Safety Historical Timeline (61 entries).

Last updated: April 2026.